Back
PTC Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
20
PTCT
PTC Therapeutics
Last Price:
$45.26
Seasonality Move:
-9.8%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$264.97
Seasonality Move:
-5.65%
Sell
20
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
-
The current PTC Therapeutics [PTCT] share price is $43.84. The Score for PTCT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
PTCT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $246.27. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $43.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $246.27Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.66 | Sell |
Relative Strength Index (14 RSI): | 46.3 | Sell |
Chaikin Money Flow: | 377324 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.71 - 47.15) | Sell |
Bollinger Bands (100): | (35.84 - 45.98) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 50.98 | Buy |
Chaikin Money Flow: | -472881 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (235.87 - 248.59) | Buy |
Bollinger Bands (100): | (244.1 - 279.08) | Sell |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.58 | Buy |
20-day SMA: | 44.84 | Sell |
50-day SMA: | 45.07 | Sell |
200-day SMA: | 36.72 | Buy |
8-day EMA: | 43.67 | Buy |
20-day EMA: | 44.6 | Sell |
50-day EMA: | 44.1 | Sell |
200-day EMA: | 38.42 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 244.96 | Buy |
20-day SMA: | 241.02 | Buy |
50-day SMA: | 248.92 | Sell |
200-day SMA: | 228.25 | Buy |
8-day EMA: | 245.27 | Buy |
20-day EMA: | 243.98 | Buy |
50-day EMA: | 249.23 | Sell |
200-day EMA: | 235.33 | Buy |
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $1.12 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and an increase next year of $4.82 per share.
PTC Therapeutics Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |